President and Chief Executive Officer
Malcolm is a serial entrepreneur and has been CEO of several venture backed equipment and expendables companies over his long career. He has worked in the medical diagnostic, analytical instrument, membrane filtration and water treatment and purification industries. Mr. Kahn earned his BA at the Pennsylvania State University and MBA at Fordham.
Mark Meyerhoff, Ph.D.
Chief Technology Officer
As the NOTA Laboratories lead co-founder, Dr. Meyerhoff has set the vision and direction for the company. Having suffered from chronic sinusitis himself, Dr. Meyerhoff is now leveraging his prior and current research at the University of Michigan to develop a novel solution to CRS. Dr. Meyerhoff’s research laboratory has been active in the field of nitric oxide release materials and their characterization, with emphasis on novel NO-releasing polymers and solutions for potential application in medicine. Dr. Meyerhoff has been working in the field nitric oxide research for >20 years.
Dr. Mark Meyerhoff is also the Philip J. Erving Professor of Chemistry at the University of Michigan Department of Chemistry, joining the university in the fall of 1979 as an Assistant Professor, and serving as a full professor since 1990. Dr. Meyerhoff sits on Scientific Advisory Boards for a number of biomedical companies. He received his Ph.D. from the State University of New York at Buffalo in 1979.
Glenn Martin, Ph.D.
Dr. Martin received his BS in Chemistry in 1985 and PhD in 1993. Dr. Martin founded Selective Technology Inc. in 1993, Analytical Chemist/Chemistry Manager at Sensicore, Inc. 2003-2008, Staff Scientist/Principal Research Scientist at Abbott Laboratories 2008-2018 and joined NOTA Labs in 2018 as Director of R&D.
Ms. Dahler received her BS in Mechanical Engineering in 2001. Ms. Dahler has worked with multiple start up’s with roles in engineering, manufacturing and supply chain. Her passion is medical devices: taking companies from R&D
Eric Pfitzenmaier has over sixteen years of experience in the pharmaceutical and medical device industries. Mr. Pfitzenmaier has served in a variety of roles including Validation Manager, Senior Equipment Engineer, and Quality and Regulatory Consultant. His product experience has spanned sterile liquid injectable, solid oral dose drug products, and class I and II medical devices. Mr. Pfitzenmaier received his Bachelor of Arts from the University of Michigan and his Masters in Biotechnology and Regulatory Compliance from Purdue University.
Chief Medical Officer
Dr. Drake is a practicing cardiac and thoracic surgeon with over 20 years of experience. He is passionate about nitric oxide's therapeutic applications and collaborates with Dr. Robert Bartlett's University of Michigan research laboratory to apply nitric oxide in cardiac surgery research. Dr. Drake received his M.D. from the University of Michigan in 1982.
Joan Keiser, Ph.D.
Dr. Keiser leads regulatory affairs at NOTA Laboratories. She spent ten years working as Vice President of Research at Pfizer. She brings a breadth of experience and network to NOTA Laboratories. Prior to joining NOTA, Dr. Keiser spent seven years as Managing Director of the University of Michigan North Campus Research Complex.
MEDICAL ADVISORY BOARD
Uma Sajjan, Ph.D.
Dr. Sajjan is a co-founder and member of the NOTA Laboratories Scientific Advisory Board. She is Associate Professor of Physiology at Temple University. Dr. Sajjan's brings extensive experience in development and execution of in vitro and in vivo models for antimicrobial and antiviral agents, and has researched extensively lower respiratory disease states and inflammatory responses.
Robert Bartlett, M.D.
University of Michigan Professor Emeritus, General Surgery. Professor Bartlett is the father of ECMO (Extracorporeal membrane oxygenation) that is used to prolong cardiac and respiratory support to persons whose heart and lungs are unable to provide an adequate amount of gas exchange or perfusion to sustain life. His lab is using NOTA's NOGEN system routinely to development additional applications for nitric oxide, including in open heart surgery and organ transplant, where NO is helping prolong the viability of organs for transplant.
Mark Zacharek, M.D.
Director of the Michigan Sinus Center
University of Michigan Professor, Otolaryngology
Marc Hershenson, M.D.
University of Michigan Professor, Pediatrics-Pulmonary Medicine
Chuanwu Xi, Ph.D.
University of Michigan Professor, Environmental Health Sciences and Global Public Health
Raimon Duran-Struuck, DVM, Ph.D.
University of Pennsylvania Associate Director, Regulatory Support and Scientist Training
University of Pennsylvania Director, Laboratory Animal Medicine Residency Program
David Brownstein, M.D.
Medical Director, Center for Holistic Medicine, Bloomfield, Michigan